TUESDAY, Jan. 10 (HealthDay News) — A drug commonly used to treat patients with Alzheimer’s disease does not appear to be effective for people older than 40 years who have Down syndrome and Alzheimer’s, according to a new study.
Read this article:
... continue reading
MONDAY, April 11 (HealthDay News) — A drug commonly prescribed for Alzheimer’s disease, memantine (Namenda), appears to be ineffective in treating the mild stage of the disease, a new study finds.
See more here:
Drug Memantine Ineffective for Mild Alzheimer’s, ... continue reading
Research on a drug commonly prescribed to Alzheimer’s disease patients is helping neuroscientists at the University of California, Berkeley, better understand perceptual learning in healthy adults.
Read the original post:
Alzheimer’s Drug Boosts Perceptual Learning In Healthy Adults